Indefinite Delivery Contract SPM20005D0916

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group, Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, valued at up to $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring medical supply needs of military health facilities worldwide. Through this single-award IDC and associated task orders, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of Department of Defense (DoD) personnel and their dependents across various military healthcare facilities. The contract has no set-aside designation and covers a period of performance from January 25, 2005 through December 31, 2025, complementing DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites.

The task orders issued under this IDC demonstrate the breadth of pharmaceutical products DMS Pharmaceutical Group supplies to the DLA, spanning common medications like antibiotics, pain relievers, and cardiovascular drugs, as well as specialized drugs such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, and oncology treatments. The firm fixed-price delivery orders, with ceiling values ranging from $53 to $83,688, are primarily placed for delivery to the DLA's medical facilities in Park Ridge, Illinois, with the contractor responsible for fulfilling these recurring military medical supply requirements.